Phase II trial of intraperitoneal carboplatin in ovarian carcinoma patients with macroscopic residual disease at second-look laparotomy : a multicentre study of the French Fédération Nationale des Centres de Lutte Contre le Cancer

Because of its antitumour activity and its pharmacological advantage when administered by the intraperitoneal route, carboplatin was studied in a phase II multicentric trial. The aim of the study was to determine the response rate and the toxicity of carboplatin administered intraperitoneally and to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 1994-02, Vol.5 (2), p.127-132
Hauptverfasser:	GUASTALLA, J. P, LHOMME, C, CHAUVIN, F, KERBRAT, P, MAYER, F, NAMER, M, GOUPIL, P, CHARROT, P, HERON, J. F, CHAZARD, M, RICHARD, I
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic agents Biological and medical sciences Carboplatin - administration & dosage Carboplatin - adverse effects Carboplatin - therapeutic use Carcinoma - drug therapy Carcinoma - mortality Carcinoma - pathology Chemotherapy Female Humans Injections, Intraperitoneal Laparotomy Medical sciences Middle Aged Ovarian Neoplasms - drug therapy Ovarian Neoplasms - mortality Ovarian Neoplasms - pathology Pharmacology. Drug treatments Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!